Home » Medtronic Terminates $738 Million EOFlow Deal
Medtronic Terminates $738 Million EOFlow Deal
Medtronic notified EOFlow on Dec. 6 that it exercised its right to terminate its agreement to acquire the company based on multiple breaches, according to a Securities Exchange Commission Form 8-K.
On May 25 Medtronic announced that it had entered into an agreement to acquire EOFlow, manufacturer of the EOPatch device, a tubeless, wearable and fully disposable insulin delivery device for $738 million.
Medtronic said it will continue to advance its automated insulin dosing product pipeline, including a differentiated patch pump.
Read the Medtronic Form 8-K here.
To read the whole story, click here to subscribe.
Related Topics
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
21Oct